Vaccines against protozoal diseases of veterinary importance

FEMS Immunology and Medical Microbiology

Volumn 15, Issue 2-3, 1996, Pages 61-72

  Cornelissen, A W C A ^a   Schetters, Th P M ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

Anaplasma; Babesia; Eimaria; Leishmania; Protozoa; Toxoplasma; Trypanosoma; Vaccine

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; LIVE VACCINE; PROTOZOAL VACCINE; RECOMBINANT VACCINE;

ANAPLASMATACEAE; BABESIA; CATTLE; LEISHMANIA; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVIEW; TOXOPLASMA; TRYPANOSOMA; VACCINATION;

EID: 0030248302     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-8244(96)00040-5     Document Type: Review

References (84)

1. [1] Milon, G. (1994) Drugs or vaccines? Parasitol. Today 10, 402-403.
2. [2] Tanner, M. and Evans, D. (1994) Vaccines or drugs: complementarity is crucial. Parasitol. Today 10, 406-407.
3. [3] Cerami, A. and Warren, K.S. (1994) Drugs. Parasitol. Today 10, 404-406.
4. [4] Joyner, L.P. and Norton, C.C. (1976) The immunity arising from continuous low-level infection with Eimeria maxima and Eimeria acervulina. Parasitology 72, 115-125.
5. [5] Johnson, J.K., McKenzie, M.E., Perry, E. and Long, P.L. (1986) The immune response of young chickens given 'graded' or 'trickle' infections with coccidia. In: Research in Avian Coccidiosis (McDougald, L.R., Joyner, L.P. and Long, P.L., Eds.), pp. 634-641. University of Goergia, Department of Poultry Science, Athens.
6. [6] Irvin, A.D. and Morrison, W.I. (1989) Vaccines against Theileria parva. In: Veterinary Protozoan and Hemoparasite Vaccines (Wright, I.G., Ed.), pp. 115-130. CRC Press, Boca Raton.
7. [7] Mauel, J. and Behin, R. (1982) Leishmaniasis: Immunity, Immunopathology and Immunodiagnosis. In: Immunology of Parasitic Infections, 2nd ed. (Cohen, S. and Warren, K.S., Eds.), pp. 299-355. Blackwell Scientific Publications, Oxford.
8. [8] Taylor, S.M. (1989) Babesia vaccines attenuated by blood passage and irradiation. In: Veterinary Protozoan and Hemoparasite Vaccines (Wright, I.G., Ed.), pp. 43-60. CRC Press, Boca Raton.
9. [9] Ristic, M. and Carson, C.A. (1977) Methods of immunoprophylaxis against bovine anaplasmosis with emphasis on the use of the attenuated Anaplasma marginale vaccine. In: Immunity to Blood Parasites of Animals and Man (Miller, L.H., Pino, J. and McKelvey, J.J., Eds.), pp. 151-173. Plenum Press, New York.
10. [10] Uggla, Arau, F.G., Lunden, A., Lovgren, K., Remington, J.S. and Morein, B.(1988) Immunizing effects in mice of two Toxoplasma gondii ISCOM preparations. J. Vet. Med. Ser. B 35, 311-314.
11. [11] Bomford, R. (1989) Adjuvants for anti-parasite vaccines, Parasitol. Today 5, 41-46.
12. [12] Kazanji, M., Laurent, F. and Pery, P. (1994) Immune responses and protective effect in mice vaccinated orally with surface sporozoite protein of Eimeria falciformis in ISCOMs. Vaccine 12, 798-804.
13. [13] Schetters, Th.P.M., Kleuskens, J., Scholtes, N. and Bos, H.J. (1992) Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture. Parasite Immunol. 14, 295-305
14. [14] Zomerdijk, J.C.M.B., Kieft, R. and Borst, P. (1991) Efficient production of functional mRNA mediated by RNA polymerase I in Trypanosoma brucei. Nature 353, 101-104.
15. [15] Roos, D.S., Donald, R.G.K., Morrisette, N.S. and Moulton, A.L.C. (1994) Molecu lar tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol. 45, 27-63.
16. [16] Cruz, A. and Beverley, S.M. (1990) Gene replacement in parasitic protozoa. Nature 348. 171-173.
17. [17] van DiJk, M.R., Janse, C.J. und Waters, A.P. (1996) Expression of a Plasmodium gene introduced into subtelomeric regions of Plasmodium berghei chromosomes. Science 271, 662-665.
18. [18] Titus, R.G., Gueiros Filho, F.J., Detreitas, L.A.R. and Beverley, S.M. (1995). Development of a safe Leishmania vaccine line by gene replacement. Proc. Natl. Acad. Sci. USA 92 (22), 10267-10271
19. [19] Cornelissen, A.W.C.A. (1988) Sex determination and sex differentiation in malaria parasites. Biol. Rev. 63, 379-394.
20. [20] Cornelissen, A.W.C.A., Overdulve, J.P. and van der Ploeg, M. (1984) Determination of nuclear DNA of five eucoccidian parasites. Isospora (Toxoplasma) gondii, Sarcocystis cruzi. Eimeria tenella, E. acervulina and Plasmodium berghei, with special reference to gamontogenesis and meiosis in I. (T.) gondii. Parasitology 88, 531-553.
21. [21] Janse, C.J., Ponnudurai, T., Lensen, A.H.W., Meuwissen, J.H.E.Th., van der Ploeg, M. and Overdulve, J.P. (1988) DNA synthesis in gametocytes of Plasmodium falciparum. Parasitology 96, 1-7.
22. [22] Walliker, D. (1994) The role of molecular genetics in field studies on malaria parasites. Int. J. Parasitol. 24, 799-808.
23. [23] Babiker, H.A., Ranfordcartwright, L.C., Currie, D., Chartwood, J.D., Billingsley, P., Teuscher, T. and Walliker, D. (1994) Random mating in natural populations of the malaria parasite Plasmodium falciparum. Parasitology 109, 423-421.
24. [24] Conway, D.J. and McBride, J.S. (1991) population genetics of Plasmodium falciparum within a malaria hyperendemic area. Parasitology 103, 7-16.
25. [25] Gibson, W. and Whittington, H. (1993) Genetic exchange in Trypanosoma brucei: selection of hybrid trypanosomes by introduction of genes conferring drug resistance. Molec. Biochem. Parasitol. 60, 19-26.
26. [26] Tait, A. and Turner, C.M.R. (1990) Genetic exchange in Trypanosoma brucei. Parasitol. Today 6, 70-75.
27. [27] Tibayrenc, M. Kjellberg, F. and Ayala, F.J. (1990). A clonal theory of parasitic protozoa: the population structure of Entamoeba, Giardia. Leishmania. Naegleria, Plasmodium, Trichomonas and Trypanosoma, and its taxonomical consequences. Proc. Natl. Acad. Sci. USA 87, 2414-2418.
28. [28] Tibayrenc, M. (1995) Population genetics and stain typing of microorganisms; how to detect departures from panmixia without individualizing alleles and loci. C.R. Acad. Sci. Paris, Sciences de la vie/Life sciences 318, 135-139.
29. [29] Borst, P. and Rudenko, G. (1994) Antigenic variation in African trypanosomes. Science 264, 1872-1873.
30. [30] Vanhamme, L. and Pays, E. (1995) Control of gene expression in trypanosomes. Microbiol. Rev. 59, 223-240.
31. [31] Baruch, D.I., Pasloske, B.L., Singh, H.B., Bi, X., Ma, X.C., Feldman, M., Taraschi, T.F. and Howard, R.J. (1995) Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82, 77-87.
32. [32] Smith, J.D., Chitnis, C.E., Craig, A.G., Roberts, D.J., Hudson-Taylor, D.E., Peterson, D.S., Pinches, R., Newbold, C.I. and Miller, L.H. (1995) Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82, 101-110.
33. [33] Su, X., Heatwole, V.M., Wertheimer, S.P., Guinet, F., Herrfeldt, J.A., Peterson, D.S., Ravetch, J.A and Wellems, T.E. (1995) The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 82, 89-100.
34. [34] Allred, D.R., Hines, S.A. and Ahrens, K.P. (1993) Isolate-specific parasite antigens of the Babesia bovis-infected erythrocyte surface. Molec. Biochem. Parasitol. 60, 121-132.
35. [35] Sergent, E., Parrot, L. and Donatien, A. (1924) A question of terminology: to immunize and to premunize. Bull. Soc. Path. Exot. 17, 37.
36. [36] Wright, I.G. (Ed.) (1989) Veterinary Protozoan and Hemoparasite Vaccines, 242 pp. CRC Press, Boca Raton.
37. [37] Schetters, T. (1995) Vaccine development from a commercial point of view. Vet. Parasitol. 57, 267-275.
38. [38] Long, P.L. (1966) The growth of some species of Eimeria in avian embryos. Parasitol. 56, 575-581.
39. [39] Jeffers, T.K. (1975) Attenuation of Eimeria tenella through selection for precociousness. J. Parasitol. 61, 1083-1090.
40. [40] Richards, F.O., Kovacs, J.A. and Luft, B.J. (1995) Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin. Infec. Dis. 21, S49-S56.
41. [41] Bos, H.J. (1993) Development of a live vaccine against ovine toxoplasmosis. In: NATO ASI Series, Toxoplasmosis (Smith, J., Ed.), pp. 231-243. Vol. H78, Springer Verlag, Berlin Heidelberg.
42. [42] Wilkins, M.F., O'Connell, E. and Te Punga, W.A. (1987) Toxoplasmosis in sheep. I. Effect of a killed vaccine on lambing losses caused by experimental challenge with Toxoplasma gondii. New Zealand Vet. J. 35, 31-34.
43. [43] Lepetit, C. (1988) Piroplasmose canine et vaccination Pirodog. Thesis Ecole Veterinaire de Nantes.
44. [44] Schetters, T. and Montenegrojames, S. (1995) Vaccines against babesiosis using soluble parasite antigens. Parasitol. Today 11, 456-462.
45. [45] Moreau, Y., Vidor, E., Bissuel, G. and Dubreuil, N. (1989) Vaccination against canine babesiosis: an overview of field observations. Trans. Roy. Soc. Trop. Med. Hyg. 83, 95-96.
46. [46] Schetters, T., Kleuskens, J., Scholtes, N. and Bos H.J. (1995) Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens. Par. Immunol. 17, 215-218.
47. [47] Ristic, M. and Wanduragala, L. (1991) Modified-live Anaplasma marginale vaccine. Anaviv. Proc. Ann. Meet U.S. Animal Hlth. Assoc. 95, 220-226.
48. [48] Kuttler, K.L., Zaugg, J.L. and Johnson, L.W. (1984) Serologic and clinical responses of premunised, vaccinated and previously infected cattle to challenge exposure by two different Anaplasma marginale. Am. J. Vet. Res. 45, 2223-2226.
49. [49] Pipano, E. (1989) Vaccination against Theileria annulata theileriosis. In: Veterinary Protozoan and Hemoparasite Vaccines (Wright, I.G., Ed.). pp. 203-234. CRC Press, Boca Raton.
50. [50] Lightowlers, M.W. (1994) Vaccination against animal parasites. Vet. Parasitol. 54, 177-204.
51. [51] Hooshmand-Rad, P. (1985) The use of tissue culture attenuated live vaccine for Theileria hirci. Devel. Biol. Standards 62, 119-127.
52. [52] Tait, A. and Hall, F.R. (1990) Theileria annulata: control measures, diagnosis and the potential use of subunit vaccines. Rev. Sci. Tech. Off. Int. Epiz. 9, 387-403.
53. [53] d'Oliveira, C., Tijhaar, E.J., Shiels, B.R., van der Weide, M. and Jongejan, F. (1996) Expression of genes encoding two major Theileria annulata merozoite antigens in Escherichia coli and a Salmonella typhimurium aroA vaccine strain. Gene 172, 33-39.
54. [54] Bock, R.E., de Vos, A.J., Lew, A., Kingston, T.G. and Fraser, I.R. (1995) Studies on failure of T strain live Babesia boris vaccine. Austr. Vet. J. 72, 296-300.
55. [55] Callow, L.L. and Dalgliesh, R.J. (1982) Immunity and immunopathology in babesiosis. In: Immunology of Parasitic Infections 2nd ed. (Cohen, S. and Warren, K.S., Eds.), pp. 475-526. Blackwell Scientific Publications. Oxford.
56. [56] Bock, R.E. de Vos, A.J., Dalgliesh, R.J. and Lew, A. (1994) Live babesiosis vaccines for cattle - The Australian experience. Eighth International Congress of Parasitology, Izmir. Turkey. Abstract p. 101.
57. [57] Echaide, I.E., Deechaide, S.T. and Guglielmone, A.A. (1993) Live and soluble antigens for cattle protection to Babesia bigemina. Vet. Parasitol. 51, 35-40.
58. [58] Dalgliesh, R.J., Callow, L.L., Mellors, L.T. and McGregor, W. (1981) Development of a highly infective Babesia bigemina vaccine of reduced virulence. Austr. Vet. J. 57, 8-11.
59. [59] Gomes, S.L. (1939) A intra-dermo-reacao de Montenegro na leishmaniose e outras perquisas afins. Brasil-Medico 53, 1079-1087.
60. [60] Mayrink, W., Williams, P., Da Costa, C.A., Magalhaes, P.A., Melo, M.N., Dias, M., Oliviera Lima, A., Michalick, M.S.M., Ferreira Carvalho, E. et al. (1985) An experimental vaccine against American dermal leishmaniasis: experience in the State of Espirito Santo. Ann. Trop. Med. Parasitol. 79, 259-269.
61. [61] Modabber, F. (1990) Development of vaccines against leishmaniasis. Scand. J. Infec. Dis., Supplement 76, 72-78.
62. [62] Jakobsen, P.H., Bate, C.W., Taverne, J. and Playfair, J.H.L. (1995) Malaria: toxins, cytokines and disease. Parasite Immunol. 17, 223-231
63. [63] Wang, H.H., Rogers, W.O., Kang, Y.H., Sedegah, M. and Huffman, S.L. (1995) Partial protection against malaria by immunisation with Leishmania enrietti expressing the Plasmodium yoelii circumsporozoite protein. Mol. Biochem. Parasitol. 69 (2) 139-148
64. [64] Chatterjee, S., Sharma, P., Kumar, S. and Chauhan, V.S. (1995) Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens. Vaccine 13 (15), 1474-1481
65. [65] Wiesmuller, K.H., Jung, G., Gillessen, D., Loffl, C., Bessler, W.G. and Boltz, T. (1991) The antibody response in BALB/c mice to the Plasmadium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant. Immunology 72, 109-113
66. [66] De Souza, J.B. and Playfair, J.H.L. (1995) A novel adjuvant for use with a blood stage malaria vaccine. Vaccine 13 (14) 1316-1319
67. [67] Byars, N.E. and Allison, A.C. (1987) Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity. Vaccine 5, 223-228
68. [68] Trinchieri, G. (1994) Interleukin 12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84. (12) 4008-4027
69. [69] Bliss, J., Van Cleave, V. Murray, K., Wiencis, A., Ketchum, M., Maylor, R., Haire, T., Resmini, C., Abbas, A.K. and Wolf, S.F. (1996) IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol. 156 (3), 887-894
70. [70] Donelly, J.J., Ulmer, J.B. and Liu, M.A. (1994) Immunization with DNA. J. Immunol. Meth. 176, 145-152.
71. [71] Waine, G.J. and McManus, D.P. (1995) Nucleic acids: vaccines of the future. Parasitol. Today 11, 113-116.
72. [72] Sedegah, M., Hedstrom, R., Hobart, P and Hoffman, S.L. (1994) Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91, 9866-9870.
73. [73] Giambrone, J.J. and Klesius, P.H. (1980) Chicken coccidiosis: correlation between resistance and delayed hypersensitivity. Poultry Sci. 59, 1715-1721.
74. [74] Lee, E.H. (1987) Vaccination against coccidiosis in commercial roaster chickens. Can. Vet. J. 28, 434-436
75. [75] Williams, R.B. (1994) Safety of the attenuated anticoccidial vaccine Paracox in broiler chickens isolated from extraneous coccidial infection. Vet. Res. Comm. 18, 189-198.
76. [76] Vertommen, M.H. (1994) Controlling coccidiosis in breeders. Poultry Int. 33, 58-63.
77. [77] Yvore, P., Naciri, M., Conan, L. and Mancassola, R. (1993) Essai du vaccin Paracox (ND) dans le control de la coccidiose chez le poulet jaune. Rev. Med. Vet. 144, 197-200.
78. [78] Bedrnik, P., Kucera, J., Firmanova, A. and Jurkovic, P. (1989) Field vaccination of broilers against coccidiosis. Avian Pathol. 18, 255-264.
79. [79] Eckert, J. (1994) Workshop Summary - Vaccination Against Coccidiosis. Vet. Parasit. 54, 331-332.
80. [80] Shirley, M.W. (1993) Live vaccines for the control of coccidiosis. Proceedings of the VIth International Coccidiosis Conference. Guelph, Canada. University of Guelph, pp. 61-72.
81. [81] Lindsay, D.S., Blagburn, B.L. and Dubey, J.P. (1993) Safety and results of challenge of weaned pigs given a temperature-sensitive mutant of Toxoplasma gondii. J. Parasitol. 79, 71-76.
82. [82] Buxton, D. (1993) Toxoplasmosis: the First Commercial Vaccine. Parasitol. Today 9, 335-337.
83. [83] Vizcaino, O., Carson, C.A., Lee, A.J. and Ristic, M. (1978) Efficacy of attenuated Anaplasma marginale vaccine under laboratory and field conditions in Colombia. Am. J. Vet. Res. 39, 229-233.
84. [84] Palmer, G.H. (1989) Anaplasma vaccines. In: Veterinary Protozoan and Hemoparasite Vaccines (Wright, I.G., Ed.), pp. 1-30. CRC Press, Boca Raton.